We are thrilled to announce that FARAGEN, a leading technical, management, and consulting group specializing in farm animal reproduction and genetic evaluation, has successfully raised $300,000 in our latest round of funding. This milestone not only reaffirms the confidence investors have in our cutting-edge methodologies and experienced team but also positions us to further innovate and expand our broad array of services. With a legacy in farm animal biotechnology that spans advanced reproductive techniques such as artificial insemination, embryo transfer, in vitro fertilization, OPU, and sophisticated semen and embryo preservation, FARAGEN has continually delivered excellence in genetic testing and breeding evaluations. Our team comprises highly qualified professionals and seasoned consultants who specialize in genomic assessments and the comprehensive evaluation of farm and animal health.
The raised funds will be strategically invested in scaling up our operations, enhancing our laboratory capabilities, and broadening our product offerings in the farm animal business sector. In addition, a significant portion of the funding is earmarked for advanced research projects that aim to further refine our biotechnology services and integrate latest developments in genetic evaluation. We are also intent on leveraging this capital to fortify our existing partnership with the government, solidifying our role in producing bovine frozen semen at the north-east animal breeding center of Iran, where a dedicated lab facility with an annual capacity of 500,000 doses continues to serve as a testament to our operational excellence since 2018. This investment marks an exciting new chapter for FARAGEN as we continue to push the boundaries of agricultural biotechnology, ensuring high-quality support and innovative solutions for our valued partners and the broader agricultural community.
